Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Evotec and C4X Discovery collaborate to discover OX1 receptor inhibitors for addiction

Jan. 19, 2015

Dr. Reddy's completes acquisition of Habitrol

Dec. 24, 2014

Temple University prepares and tests novel glutamate uptake modulators

Dec. 23, 2014

Noribogaine HCl safe and well tolerated in healthy volunteers

Dec. 12, 2014

Researchers present novel radiomitigating compounds

Nov. 28, 2014

PRO-028 and PRO-027: novel NAC analogues for cocaine addiction

Nov. 26, 2014

RGFP-966, an epigenetic HDAC3 inhibitor, tested in a rat cocaine-abuse model

Nov. 17, 2014

Eisai and Arena report phase II data for lorcaserin in smoking cessation

Nov. 4, 2014

Orexo applies to FDA to expand Zubsolv label to include initiation of opioid dependence therapy

Oct. 13, 2014

Japanese approval for fomepizole to treat ethylene glycol and methanol poisonings

Sep. 26, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...